e-Drug3D 1444 |
PLICAMYCIN DISCONTINUED
|
cas 18378-89-7 |
CLASS ANTINEOPLASTIC |
ROUTE (list) INJECTION |
NATURAL MOLECULE (link) ATC code |
PK parameters |
Target TARGET DNA PDB Ligand code = QWP (link to the list of PDB complexes) Download experimental 3D coordinates of QWP with added hydrogens |
DrugCentral Unknown |
Download SDF file | D-threo-2-Pentulose, 5-deoxy-1-C-[(2S,3S)-7-[[2,6-dideoxy-3-O-(2,6-dideoxy-.beta.-D-arabino-hexopyranosyl)-.beta.-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-.beta.-D-ribo-hexopyranosyl-(13)-O-2,6-dideoxy-.beta.-D-lyxo-hexopyranosyl-(13)-2,6-dideoxy-.beta.-D-arabino-hexopyranosyl)oxy]-1,2,3,4-tetrahydro-5,10-dihydroxy-6-methyl-4-oxo-2-anthracenyl]-1-O-methyl-, (1S)- (9CI) Formula: Calculated chemical properties: MW 1085.13 NB_atoms 76 XLogP -0.25 PSA 346.579 NB_HD 11 NB_HA 24 fsp3 0.77 Lipinski(0=no;1=yes) 0 |
FDA NDA 050109 (pdf not found) INN (PLICAMYCIN) MITHRACIN (PFIZER) APPROVAL= AP YEAR= 1970 NEWMOLECULARENTITY DISCONTINUED |
Other links: |